Doctors at his hospital are using it despite the lack of research on whether patients are actually benefiting.unfortunately - so we are doing the best we can with applying the best supportive care that we can. But there's a lot we don't know about this disease.
"The early French study, which prompted all the interest in this drug, was in 20 patients, a very small subset and no controls and only a very small subset had the combination of azithromycin and hydroxychloroquine," says Dr Sterman. "My hope is that these randomised trials will give us definitive information as to whether or not hydroxychloroquine or is effective in COVID-19 patients," says Dr Sterman.
"'I think we struggle, all the doctors who are caring for these patients around the world are struggling with two things," says Dr Sterman."One is our desperate desire to find a drug that works and a willingness to try anything to try to save our patients."